88IV - PR Newswire Asia's news


S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Accro Bioscience Announces First Patient Dosed in Phase IIb Study of AC-101 in Moderate-to-Severe Ulcerative Colitis NEW YORK and SUZHOU, China , Sept. 20, 2026 /PRNewswire/ -- Accro Bioscience Inc. (Accro Bio), a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem SHANGHAI , Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fosun Health Hosts First International Oncology Treatment Forum in Foshan; International Oncology Alliance Officially Established FOSHAN, China , Sept. 20, 2026 /PRNewswire/ -- The first International Oncology Treatment Forum, hosted by Fosun Health, was held in Foshan, Guangdong Province, China. Oncology experts from multiple ... 2026-09-20T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NAVER D2SF Invests in AI-Driven Precision Medicine Company ImpriMed ImpriMed combines ex vivo functional testing with multimodal AI to support personalized cancer treatment decisions and drug development The investment is part of ImpriMed's $10 million Series A2 bridge ... 2026-09-18T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026 GENEVA , Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally ... 2026-09-18T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
2026 Tang Prize Award Ceremony Honors Six Laureates Outstanding Achievements for Global Well-Being and Our Shared Future ... 2026-09-18T Biotechnology Health Care/Hospital Higher Education Medical/Pharmaceuticals
A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4% PARIS , Sept. 18, 2026 /PRNewswire/ -- ... 2026-09-18T Agriculture Banking/Financial Service Biotechnology Household/Consumer/Cosmetics
New Peer-Reviewed Study Confirms Innovative Technology Shatters ESR's Four-Hour Deadline ALCOR Scientific's iSED® analyzers reshape lab logistics and improve patient care for one of medicine's most widely used tests ... 2026-09-17T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR — Combining Both Companies' Astatine At-211 Assets, Development Capabilities, and Supply Chains to Create a Global Targeted Alpha Therapy Company — ... 2026-09-17T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology